CDMO Expertise Cerbios-Pharma is a multi-disciplinary CDMO with end-to-end capabilities from API and HPAPI development to payloads, ADCs, proteins, and antibodies, offering integrated manufacturing from concept to commercial supply. This positions them as a one-stop partner for pharmaceutical companies seeking scale-up and regulatory-ready CMC support.

ADC specialists Their dedicated Proveo ADC division provides payload synthesis, conjugation, and robust CMC and regulatory backing, making Cerbios an attractive supplier for biotech firms pursuing antibody-drug conjugate programs that require integrated manufacturing workflows.

HPAPI & Probiotics With leadership in high-potency active ingredients and proprietary probiotic strain Enterococcus faecium SF68, Cerbios appeals to partners in oncology, specialized biologics, and animal health sectors seeking reliable HPAPI production and probiotic manufacturing capabilities.

Swiss Precision Rooted in Swiss precision with facilities in Lugano and Couvet and as part of the HAS Group, Cerbios emphasizes quality and global supply reliability, a compelling value proposition for partners needing compliant, scalable manufacturing with robust QA/regulatory support.

Growth & Partnerships Revenue in the small-to-mid market range and a history of leadership appointments indicate a growth-oriented organization open to collaborations, technology licensing, and development partnerships across pharma-substance production, HPAPI, and animal health solutions.